
FDA approves carfilzomib and daratumumab with dexamethasone for multiple myeloma
On August 20, 2020, the Food and Drug Administration approved carfilzomib and daratumumab in combination…
On August 20, 2020, the Food and Drug Administration approved carfilzomib and daratumumab in combination…
The Food and Drug Administration (FDA) approved daratumumab and hyaluronidase-fihj for adult patients with newly…
Adding daratumumab to carfilzomib and dexamethasone to treat patients with relapsed or refractory multiple myeloma…
The phase 3 ALCYONE study showed the addition of daratumumab to bortezomib, melphalan and prednisone (D-VMP) improved…
Interim results from a large international phase III clinical trial show that adding the immunotherapy…
ASH: Myeloma is cancer of the plasma cells, white blood cells that produce infection-fighting antibodies.…